サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1404777

マイクロ流体の市場規模、シェア、動向分析レポート：用途別、材料別、技術別、地域別、セグメント予測、2024年～2030年

Microfluidics Market Size, Share & Trends Analysis Report By Application (Medical/Healthcare, Non-Medical), By Material (Silicon, Glass), By Technology, By Region, And Segment Forecasts, 2024 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 200 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
マイクロ流体の市場規模、シェア、動向分析レポート：用途別、材料別、技術別、地域別、セグメント予測、2024年～2030年
出版日: 2023年11月27日
発行: Grand View Research
ページ情報: 英文 200 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

マイクロ流体市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界のマイクロフルイディクス市場規模は、2024年から2030年にかけて12.22%のCAGRを記録し、2030年には719億米ドルに達すると予測されています。

オンチップ生化学分析を可能にするデジタルマイクロフルイディクスなどの改良された技術のイントロダクションより、マイクロフルイディクスベースのデバイスの需要が増加する見込みです。分析および臨床研究者による研究活動の増加も、マイクロ流体デバイスの需要を押し上げています。例えば、2022年5月、ミネソタ大学の研究チームは、最小限の部品しか使用せず、スマートフォンでワイヤレスに操作できる病気診断用の革新的なマイクロ流体チップを開発しました。

小型のマイクロ流体ベースのツールは消費者の間で大きな人気を集めており、それが企業の開発投資を後押ししています。マイクロ流体工学はラボ・オン・ア・チップ・デバイスの基本原理であるため、最小限のサンプル量、最小限の試薬使用量、廃棄物の削減、迅速な処理など、さまざまな利点があります。機能強化された完全自動のマイクロフルイディクスと強固なモジュール性は、この市場で事業を展開するメーカーに成長機会をもたらしています。これは、モジュラーチップが複数の機器とインターフェースできることに起因しています。さらに、創薬分野で事業を展開する企業は、特許切れとなる薬剤の多さに起因する収益減少の見込みを相殺するため、諸経費とスケジュールの最小化に努めています。

マイクロ流体工学の導入は、診断分野、特にPOC診断において拡大しています。これはまた、POC診断の強化が期待されるマイクロ流体一体型バイオセンサー技術によっても補完されています。マイクロ流体コンポーネントとPOCデバイスの組み合わせは、感度、安定性、精度、手頃な価格を達成し、低侵襲のPOC技術を得ることに主眼が置かれています。マイクロ流体POC技術は、個別化、疾患の早期発見、容易なモニタリングを保証することで、患者のケアを強化すると期待されています。

さらに、COVID-19はマイクロ流体工学の使用をさらに拡大しました。ポイント・オブ・ケア検査は、小型の装置を使用し、プロセスを制御し、検査サイクルを制限します。これによって、単一または複数の調査研究室サービスが生物学的サンプルを評価し、有害な病気を同時に診断することができます。一般に、ウイルス流行の段階的評価と迅速な検出は、パンデミックの状況を克服し、迅速に診断するために不可欠です。そのため、マイクロ流体デバイスとポイントオブケア検査を組み合わせることで、検出効率を高めることができます。同時に、マイクロ流体チップを用いたポイントオブケア検査は、ユーザーの利便性を高め、感度と精度を向上させ、検出時間を短縮します。

さらに、マイクロ流体業界におけるいくつかの買収は、マイクロ流体関連の応用範囲を拡大するための技術強化を目的としています。2021年6月、ダナハー・コーポレーションはカナダを拠点とするソリューション・プロバイダー、プレシジョン・ナノシステムズ（PNI）をライフサイエンス事業が買収したと発表しました。PNI社は、マイクロ流体ベースのプラットフォームを介したLNPデリバリーやナノ粒子製造など、独自の遺伝子ツールキットプラットフォームを提供し、同社のライフサイエンス製品ポートフォリオをさらに補完していました。

一方、高い運用コストがマイクロ流体市場の成長をある程度妨げています。マイクロ流体チップの製造には、最終的な密閉構造を形成するために機械部品の接着を必要とするオープンチャンネル構造などの問題があります。オープン・チャンネルはガラスやシリコンのエッチングによって形成されます。このステップは時間がかかり、コストが高く、攻撃的な化学薬品を使用する必要があります。さらに、マイクロ流体のプロトタイピング手法のほとんどは、バッチプロセスに対応しておらず、複雑でコストもかかります。

マイクロ流体市場レポートハイライト

  • 用途別では、医療分野が2023年に市場で最も高い収益シェアを占め、2024～2030年のCAGRは12.56%と予測されます。
  • 材料別では、ポリジメチルシロキサン（PDMS）分野が2023年に最も高い市場シェアを占め、2024～2030年のCAGRは13.59％と予想されています。
  • 技術別では、ラボオンチップセグメントが2023年に市場を独占し、予測期間中のCAGRは11.06%になると予測されています。
  • 北米は、2023年に42.69％の収益シェアで市場を独占し、予測期間中に10.57％のCAGRを示すと予測されています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 市場変数、動向、および範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
    • 市場機会分析
  • 業界分析ツール
    • SWOT分析;要因別（政治・法律、経済・技術）
    • ポーターのファイブフォース分析
  • COVID-19感染症の影響分析

第4章 マイクロ流体市場：用途ビジネス分析

  • マイクロ流体市場：用途の変動分析
  • 医療
    • PCRおよびRT-PCR
    • ゲル電気泳動
    • マイクロアレイ
    • エリサ
    • その他
  • 非医療用

第5章 マイクロ流体市場：材料ビジネス分析

  • マイクロ流体市場：物質変動分析
  • ケイ素
  • ガラス
  • ポリマー
  • ポリジメチルシロキサン（PDMS）
  • その他

第6章 マイクロ流体市場：テクノロジービジネス分析

  • マイクロ流体市場：技術変動分析
  • ラボオンチップ
    • 医療
    • 非医療
  • 臓器オンチップ
    • 医療
    • 非医療
  • 連続流マイクロフルイディクス
    • 医療
    • 非医療
  • 光流体工学とマイクロ流体工学
    • 医療
    • 非医療
  • 音響流体工学とマイクロ流体工学
    • 医療
    • 非医療
  • 電気泳動とマイクロ流体工学
    • 医療
    • 非医療

第7章 地域ビジネス分析

  • 地域別マイクロ流体市場シェア、2023年および2030年
  • 北米
    • 北米マイクロ流体市場、2018年から2030年
    • 米国
    • カナダ
  • 欧州
    • 欧州のマイクロ流体市場、2018年から2030年
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋地域
    • アジア太平洋マイクロ流体市場、2018年から2030年
    • 日本
    • 中国
    • インド
    • オーストラリア
    • タイ
    • 韓国
  • ラテンアメリカ
    • ラテンアメリカのマイクロ流体市場、2018年から2030年
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • MEAマイクロ流体市場、2018年～2030年
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第8章 競合情勢

  • 企業の分類
  • 戦略マッピング
  • 企業の市況分析、2023年
  • 企業プロファイル
    • Illumina, Inc.
    • F. Hoffmann-La Roche Ltd
    • PerkinElmer, Inc
    • Agilent Technologies, Inc
    • Bio-Rad Laboratories, Inc
    • Danaher Corporation
    • Abbott
    • Thermo Fisher Scientific Inc.
    • Standard BioTools, Inc.
図表

List of Tables

  • Table 1 Some commercialized POCT devices based on NAT.
  • Table 2 List of FDA-approved microfluidic-based POC tests
  • Table 3 Research institutes in Canada working on microfabricated microfluidics
  • Table 4 Overview of magnetic, colorimetric, plasmonic, electrochemical, and lateral flow assays
  • Table 5 Several approaches for microfluidic PCR devices including commercial PCR devices
  • Table 6 Major types of micro mosaic immunoassays
  • Table 7 Particle-focusing techniques applied in microfluidic flow cytometry
  • Table 8 Comparison of detection of food allergens by commercial ELISA kits and the microfluidic ELISA biosensor
  • Table 9 Materials and their respective technologies for micro structuring
  • Table 10 Comparison of polymers with glass
  • Table 11 Distinctive features of continuous-flow microfluidics and their usage in materials synthesis
  • Table 12 Different applications of acoustofluidic separation
  • Table 13 List of established companies
  • Table 14 List of emerging companies (contd.)
  • Table 15 List of Secondary Sources
  • Table 16 List of Abbreviations
  • Table 17 Global Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 18 Global Microfluidics Market, by Material, 2018 - 2030 (USD Million)
  • Table 19 Global Microfluidics Market, by Application, 2018 - 2030 (USD Million)
  • Table 20 Global Microfluidics Market, by Region, 2018 - 2030 (USD Million)
  • Table 21 North America Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 22 North America Microfluidics Market, by Material, 2018 - 2030 (USD Million)
  • Table 23 North America Microfluidics Market, by Application, 2018 - 2030 (USD Million)
  • Table 24 U.S. Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 25 U.S. Microfluidics Market, by Material, 2018 - 2030 (USD Million)
  • Table 26 U.S. Microfluidics Market, by Application, 2018 - 2030 (USD Million)
  • Table 27 Canada Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 28 Canada Microfluidics Market, by Material, 2018 - 2030 (USD Million)
  • Table 29 Canada Microfluidics Market, by Application, 2018 - 2030 (USD Million)
  • Table 30 Europe Microfluidics Market, by Country, 2018 - 2030 (USD Million)
  • Table 31 Europe Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 32 Europe Microfluidics Market, by Material, 2018 - 2030 (USD Million)
  • Table 33 Europe Microfluidics Market, by Application, 2018 - 2030 (USD Million)
  • Table 34 Germany Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 35 Germany Microfluidics Market, by Material, 2018 - 2030 (USD Million)
  • Table 36 Germany Microfluidics Market, by Application, 2018 - 2030 (USD Million)
  • Table 37 UK Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 38 UK Microfluidics Market, by Material, 2018 - 2030 (USD Million)
  • Table 39 UK Microfluidics Market, by Application, 2018 - 2030 (USD Million)
  • Table 40 Norway Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 41 Norway Microfluidics Market, by Material, 2018 - 2030 (USD Million)
  • Table 42 Norway Microfluidics Market, by Application, 2018 - 2030 (USD Million)
  • Table 43 Sweden Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 44 Sweden Microfluidics Market, by Material, 2018 - 2030 (USD Million)
  • Table 45 Sweden Microfluidics Market, by Application, 2018 - 2030 (USD Million)
  • Table 46 Denmark Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 47 Denmark Microfluidics Market, by Material, 2018 - 2030 (USD Million)
  • Table 48 Denmark Microfluidics Market, by Application, 2018 - 2030 (USD Million)
  • Table 49 France Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 50 France Microfluidics Market, by Material, 2018 - 2030 (USD Million)
  • Table 51 France Microfluidics Market, by Application, 2018 - 2030 (USD Million)
  • Table 52 Italy Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 53 Italy Microfluidics Market, by Material, 2018 - 2030 (USD Million)
  • Table 54 Italy Microfluidics Market, by Application, 2018 - 2030 (USD Million)
  • Table 55 Asia Pacific Microfluidics Market, by Country, 2018 - 2030 (USD Million)
  • Table 56 Asia Pacific Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 57 Asia Pacific Microfluidics Market, by Material, 2018 - 2030 (USD Million)
  • Table 58 Asia Pacific Microfluidics Market, by Application, 2018 - 2030 (USD Million)
  • Table 59 China Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 60 China Microfluidics Market, by Material, 2018 - 2030 (USD Million)
  • Table 61 China Microfluidics Market, by Application, 2018 - 2030 (USD Million)
  • Table 62 Japan Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 63 Japan Microfluidics Market, by Material, 2018 - 2030 (USD Million)
  • Table 64 Japan Microfluidics Market, by Application, 2018 - 2030 (USD Million)
  • Table 65 India Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 66 India Microfluidics Market, by Material, 2018 - 2030 (USD Million)
  • Table 67 India Microfluidics Market, by Application, 2018 - 2030 (USD Million)
  • Table 68 Australia Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 69 Australia Microfluidics Market, by Material, 2018 - 2030 (USD Million)
  • Table 70 Australia Microfluidics Market, by Application, 2018 - 2030 (USD Million)
  • Table 71 Thailand Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 72 Thailand Microfluidics Market, by Material, 2018 - 2030 (USD Million)
  • Table 73 Thailand Microfluidics Market, by Application, 2018 - 2030 (USD Million)
  • Table 74 Latin America Microfluidics Market, by Country, 2018 - 2030 (USD Million)
  • Table 75 Latin America Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 76 Latin America Microfluidics Market, by Material, 2018 - 2030 (USD Million)
  • Table 77 Latin America Microfluidics Market, by Application, 2018 - 2030 (USD Million)
  • Table 78 Brazil Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 79 Brazil Microfluidics Market, by Material, 2018 - 2030 (USD Million)
  • Table 80 Brazil Microfluidics Market, by Application, 2018 - 2030 (USD Million)
  • Table 81 Mexico Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 82 Mexico Microfluidics Market, by Material, 2018 - 2030 (USD Million)
  • Table 83 Mexico Microfluidics Market, by Application, 2018 - 2030 (USD Million)
  • Table 84 Argentina Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 85 Argentina Microfluidics Market, by Material, 2018 - 2030 (USD Million)
  • Table 86 Argentina Microfluidics Market, by Application, 2018 - 2030 (USD Million)
  • Table 87 Middle East & Africa Microfluidics Market, by Country, 2018 - 2030 (USD Million)
  • Table 88 Middle East & Africa Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 89 Middle East & Africa Microfluidics Market, by Material, 2018 - 2030 (USD Million)
  • Table 90 Middle East & Africa Microfluidics Market, by Application, 2018 - 2030 (USD Million)
  • Table 91 South Africa Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 92 South Africa Microfluidics Market, by Material, 2018 - 2030 (USD Million)
  • Table 93 South Africa Microfluidics Market, by Application, 2018 - 2030 (USD Million)
  • Table 94 Saudi Arabia Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 95 Saudi Arabia Microfluidics Market, by Material, 2018 - 2030 (USD Million)
  • Table 96 Saudi Arabia Microfluidics Market, by Application, 2018 - 2030 (USD Million)
  • Table 97 UAE Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 98 UAE Microfluidics Market, by Material, 2018 - 2030 (USD Million)
  • Table 99 UAE Microfluidics Market, by Application, 2018 - 2030 (USD Million)
  • Table 100 Kuwait Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 101 Kuwait Microfluidics Market, by Material, 2018 - 2030 (USD Million)
  • Table 102 Kuwait Microfluidics Market, by Application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Information procurement
  • Fig. 2 Primary research pattern
  • Fig. 3 Market research approaches
  • Fig. 4 Value-chain-based sizing & forecasting
  • Fig. 5 QFD modeling for market share assessment
  • Fig. 6 Market formulation & validation
  • Fig. 7 Microfluidics market estimation process
  • Fig. 8 Market snapshot
  • Fig. 9 Market trends & outlook
  • Fig. 10 Microfluidics market segmentation
  • Fig. 11 Penetration and growth prospect mapping
  • Fig. 12 SWOT analysis, by factor (Political & legal, economic, and technological)
  • Fig. 13 Porter's five forces analysis
  • Fig. 14 Market driver impact
  • Fig. 15 Market restraint impact
  • Fig. 16 Emerging applications of automated and miniaturized microfluidics
  • Fig. 17 Companies developing automated and miniaturized microfluidics
  • Fig. 18 Extending applications of microfluidics technology
  • Fig. 19 Photolithographic procedure
  • Fig. 20 Types of COVID-19 tests
  • Fig. 21 Advantages of lab-on-chip devices for COVID-19 testing
  • Fig. 22 Microfluidics market: technology outlook and key takeaways
  • Fig. 23 Microfluidics market: technology movement analysis
  • Fig. 24 Microfluidics market estimates and forecast for medical technologies, 2018 - 2030 (USD Million)
  • Fig. 25 Microfluidics market estimates and forecast for PCR & RT-PCR, 2018 - 2030 (USD Million)
  • Fig. 26 Microfluidics market estimates and forecast for gel electrophoresis, 2018 - 2030 (USD Million)
  • Fig. 27 Microfluidics market estimates and forecast for microarrays, 2018 - 2030 (USD Million)
  • Fig. 28 Microfluidics market estimates and forecast for ELISA, 2018 - 2030 (USD Million)
  • Fig. 29 Different detection methods for microfluidic flow cytometry
  • Fig. 30 Microfluidics market estimates and forecast for other technologies, 2018 - 2030 (USD Million)
  • Fig. 31 Microfluidics market estimates and forecast for non-medical technologies, 2018 - 2030 (USD Million)
  • Fig. 32 Microfluidics market: material outlook and key takeaways
  • Fig. 33 Microfluidics market: material movement analysis
  • Fig. 34 Pros and cons of silicon
  • Fig. 35 Microfluidics market estimates and forecast for silicon, 2018 - 2030 (USD Million)
  • Fig. 36 Advantages of glass as microfluidic material
  • Fig. 37 Microfluidics market estimates and forecast for glass, 2018 - 2030 (USD Million)
  • Fig. 38 Types of polymers used to develop microfluidic devices
  • Fig. 39 Microfluidics market estimates and forecast for polymer, 2018 - 2030 (USD Million)
  • Fig. 40 Microfluidics market estimates and forecast for PDMS, 2018 - 2030 (USD Million)
  • Fig. 41 Microfluidics market estimates and forecast for other materials, 2018 - 2030 (USD Million)
  • Fig. 42 Microfluidics market: application outlook and key takeaways
  • Fig. 43 Microfluidics market: Application movement analysis
  • Fig. 44 Microfluidics market estimates and forecast for lab-on-a-chip, 2018 - 2030 (USD Million)
  • Fig. 45 Medical lab-on-a-chip market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 Non-medical lab-on-a-chip market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 Microfluidics market estimates and forecast for organs-on-chip, 2018 - 2030 (USD Million)
  • Fig. 48 Medical organs-on-chip market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 49 Non-medical organs-on-chip market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 Microfluidics market estimates and forecast for continuous flow microfluidics, 2018 - 2030 (USD Million)
  • Fig. 51 Medical continuous flow microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 Non-medical continuous flow microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 Microfluidics market estimates and forecast for optofluidics and microfluidics, 2018 - 2030 (USD Million)
  • Fig. 54 Medical optofluidics and microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 Non-medical optofluidics and microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 Microfluidics market estimates and forecast for acoustofluidics and microfluidics, 2018 - 2030 (USD Million)
  • Fig. 57 Medical applications of acoustofluidics
  • Fig. 58 Medical acoustofluidics and microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 59 Non-medical acoustofluidics and microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 60 Microfluidics market estimates and forecast for electrophoresis and microfluidics, 2018 - 2030 (USD Million)
  • Fig. 61 Medical electrophoresis and microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 62 Non-medical electrophoresis and microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 63 Regional marketplace: regional outlook and key takeaways
  • Fig. 64 Microfluidics regional outlook, 2021 & 2030
  • Fig. 65 North America microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 66 U.S. microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 67 Canada microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 68 Europe microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 69 Germany microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 70 UK microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 71 France microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 72 Italy microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 73Denmark microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 74 Norway microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 75 Sweden microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 76 Asia Pacific microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 77 Japan microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 78 China microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 79 India microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 80 Australia microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 81 Thailand microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 82 Latin America microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 83 Brazil microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 84 Mexico microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 85 Argentina microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 86 MEA microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 87 South Africa microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 88 Saudi Arabia microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 89 UAE microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 90 Kuwait microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 91 Strategy framework
  • Fig. 92 Participant categorization 
目次
Product Code: GVR-1-68038-056-9

Microfluidics Market Growth & Trends:

The global microfluidics market size is expected to reach USD 71.90 billion by 2030, registering CAGR of 12.22% from 2024 to 2030, according to a new report by Grand View Research, Inc. The demand for microfluidics-based devices is expected to increase due to the introduction of improved technology such as digital microfluidics, which enables on-chip biochemical analysis. An increase in research activities undertaken by analytical and clinical researchers have also driven the demand for microfluidics device. For instance, in May 2022, a research team from the University of Minnesota developed an innovative microfluidic chip for disease diagnosing that uses a minimum number of components and can be operated wirelessly by a smartphone.

Miniature microfluidic-based tools are gaining significant popularity among consumers, which has encouraged companies to invest in their development. Since microfluidics is the underlying principle of lab-on-a-chip devices, it offers various benefits such as minimal sample volume, minimal reagent usage, reduced waste, and rapid processing. Fully automated microfluidics with enhanced functional capabilities, and robust modularity are creating growth opportunities for manufacturers operating in the market. This can be attributed to the fact that modular chips can interface with several instruments. In addition, companies operating in the field of drug discovery are striving to minimize overhead costs and timelines to offset the estimated decline in revenue owing to a significant number of drugs going off-patent.

The implementation of microfluidics is expanding in the field of diagnostics, especially in POC diagnostics. This is also supplemented by microfluidics-integrated biosensor technologies that are expected to enhance POC diagnostics. The combination of microfluidic components with POC devices is largely focused on achieving sensitivity, stability, accuracy, affordability, and obtaining minimally invasive POC technology. Microfluidic POC technologies are expected to enhance patient care by ensuring personalization, early disease detection, and easy monitoring.

In addition, COVID-19 has further upscaled the use of microfluidics. Point-of-care testing involves small equipment, regulates the process, and has limited testing cycles. This allows single or multiple research laboratory services to evaluate biological samples and diagnose harmful diseases simultaneously. In general, stage assessment and rapid detection of viral epidemics are vital to overcoming pandemic situations and diagnosing rapidly. Therefore, combining microfluidic devices with point-of-care testing enhances detection efficiency. At the same time, point-of-care testing of microfluidic chips enhances user accessibility, improves sensitivity and accuracy, and reduces the detection time, all of which are advantageous in detecting SARS-CoV-2.

Further, several acquisitions in the microfluidics industry are aimed at enhancing technologies for expanding the scope of microfluidics-related applications. In June 2021, Danaher Corporation announced that Precision NanoSystems (PNI), a Canada-based solution provider, was acquired by its life science business. PNI offered proprietary genetic toolkit platforms, including LNP delivery and nanoparticle manufacturing via the microfluidic-based platform, which further complemented the company's portfolio of life science products.

On the other hand, high operational costs hinder the microfluidics market growth to a certain extent. The fabrication of microfluidics chips has certain issues such as open channel construction that require bonding of machine parts to form a final enclosed structure. The open channel is formed by the etching of glass or silicon. This step is slow, costly, and requires the use of aggressive chemicals. In addition, most of the microfluidic prototyping methods are not compatible with the batch process, and are also complicated and costly.

Microfluidics Market Report Highlights:

  • Based on application, the medical segment held the highest revenue share of the market in 2023 and is expected to exhibit a CAGR of 12.56% from 2024-2030.
  • Based on material, the polydimethylsiloxane (PDMS) segment held the highest market share in 2023 and is expected to grow at a CAGR of 13.59% from 2024-2030.
  • Based on technology, the lab-on-a-chip segment dominated the market in 2023 and is expected to reveal a CAGR of 11.06% during the forecast period.
  • North America dominated the market with a revenue share of 42.69% in 2023 and is projected to exhibit a CAGR of 10.57% during the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Information Analysis
    • 1.2.2. Market Application & Data Visualization
    • 1.2.3. Data Validation & Publishing
  • 1.3. Research Assumptions
  • 1.4. Information Procurement
    • 1.4.1. Primary Research
  • 1.5. Information or Data Analysis
  • 1.6. Market Application & Validation
  • 1.7. Market Model
  • 1.8. Global Market: CAGR Calculation
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing demand for low-volume sample analysis
      • 3.2.1.2. Growing penetration of microfluidics in diagnostics market
      • 3.2.1.3. Introduction of advanced technologies
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High operational cost
      • 3.2.2.2. Interfacing and integration
      • 3.2.2.3. Complex fabrication process
    • 3.2.3. Market Opportunity Analysis
      • 3.2.3.1. Investments by companies in technological advancements
      • 3.2.3.2. Growing adoption of point-of-care (POC) tests
      • 3.2.3.3. Expansion of application scope for microfluidics technology
  • 3.3. Industry Analysis Tools
    • 3.3.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
    • 3.3.2. Porter's Five Forces Analysis
  • 3.4. COVID-19 Impact Analysis

Chapter 4. Microfluidics Market: Application Business Analysis

  • 4.1. Microfluidics Market: Application Movement Analysis
  • 4.2. Medical
    • 4.2.1. PCR & RT-PCR
      • 4.2.1.1. Global PCR & RT-PCR Market, 2018 - 2030 (USD Million)
    • 4.2.2. Gel electrophoresis
      • 4.2.2.1. Global Gel electrophoresis Market, 2018 - 2030 (USD Million)
    • 4.2.3. Microarrays
      • 4.2.3.1. Global Microarrays Market, 2018 - 2030 (USD Million)
    • 4.2.4. ELISA
      • 4.2.4.1. Global ELISA Market, 2018 - 2030 (USD Million)
    • 4.2.5. Others
      • 4.2.5.1. Global Others Market, 2018 - 2030 (USD Million)
  • 4.3. Non-Medical
    • 4.3.1. Global Non-Medical Market, 2018 - 2030 (USD Million)

Chapter 5. Microfluidics Market: Material Business Analysis

  • 5.1. Microfluidics Market: Material Movement Analysis
  • 5.2. Silicon
    • 5.2.1. Global Silicon Market, 2018 - 2030 (USD Million)
  • 5.3. Glass
    • 5.3.1. Global Glass Market, 2018 - 2030 (USD Million)
  • 5.4. Polymer
    • 5.4.1. Global Polymer Market, 2018 - 2030 (USD Million)
  • 5.5. Polydimethylsiloxane (PDMS)
    • 5.5.1. Global Polydimethylsiloxane (PDMS) Market, 2018 - 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Global Others Market, 2018 - 2030 (USD Million)

Chapter 6. Microfluidics Market: Technology Business Analysis

  • 6.1. Microfluidics Market: Technology Movement Analysis
  • 6.2. Lab-on-a-chip
    • 6.2.1. Global Lab-on-a-chip Market, 2018 - 2030 (USD Million)
    • 6.2.2. Medical
      • 6.2.2.1. Medical Market, 2018 - 2030 (USD Million)
    • 6.2.3. Non-medical
      • 6.2.3.1. Non-medical Market, 2018 - 2030 (USD Million)
  • 6.3. Organs-on-chips
    • 6.3.1. Global Organs-on-chips Market, 2018 - 2030 (USD Million)
    • 6.3.2. Medical
      • 6.3.2.1. Medical Market, 2018 - 2030 (USD Million)
    • 6.3.3. Non-medical
      • 6.3.3.1. Non-medical Market, 2018 - 2030 (USD Million)
  • 6.4. Continuous flow microfluidics
    • 6.4.1. Global Continuous Flow Microfluidics Market, 2018 - 2030 (USD Million)
    • 6.4.2. Medical
      • 6.4.2.1. Medical Market, 2018 - 2030 (USD Million)
    • 6.4.3. Non-medical
      • 6.4.3.1. Non-medical Market, 2018 - 2030 (USD Million)
  • 6.5. Optofluidics and microfluidics
    • 6.5.1. Global Optofluidics and microfluidics Market, 2018 - 2030 (USD Million)
    • 6.5.2. Medical
      • 6.5.2.1. Medical Market, 2018 - 2030 (USD Million)
    • 6.5.3. Non-medical
      • 6.5.3.1. Non-medical Market, 2018 - 2030 (USD Million)
  • 6.6. Acoustofluidics and microfluidics
    • 6.6.1. Global Acoustofluidics and microfluidics Market, 2018 - 2030 (USD Million)
    • 6.6.2. Medical
      • 6.6.2.1. Medical Market, 2018 - 2030 (USD Million)
    • 6.6.3. Non-medical
      • 6.6.3.1. Non-medical Market, 2018 - 2030 (USD Million)
  • 6.7. Electrophoresis and microfluidics
    • 6.7.1. Global Electrophoresis and microfluidics Market, 2018 - 2030 (USD Million)
    • 6.7.2. Medical
      • 6.7.2.1. Medical Market, 2018 - 2030 (USD Million)
    • 6.7.3. Non-medical
      • 6.7.3.1. Non-medical Market, 2018 - 2030 (USD Million)

Chapter 7. Regional Business Analysis

  • 7.1. Microfluidics Market Share By Region, 2023 & 2030
  • 7.2. North America
    • 7.2.1. North America Microfluidics Market, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. Key Country Dynamics
      • 7.2.2.2. Target disease prevalence
      • 7.2.2.3. Competitive Scenario
      • 7.2.2.4. Regulatory Framework
      • 7.2.2.5. U.S. Microfluidics Market, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Key Country Dynamics
      • 7.2.3.2. Target disease prevalence
      • 7.2.3.3. Competitive Scenario
      • 7.2.3.4. Regulatory Framework
      • 7.2.3.5. Canada Microfluidics Market, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Microfluidics Market, 2018 - 2030 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Target disease prevalence
      • 7.3.2.3. Competitive Scenario
      • 7.3.2.4. Regulatory Framework
      • 7.3.2.5. UK Microfluidics Market, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Target disease prevalence
      • 7.3.3.3. Competitive Scenario
      • 7.3.3.4. Regulatory Framework
      • 7.3.3.5. Germany Microfluidics Market, 2018 - 2030 (USD Million)
    • 7.3.4. France
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Target disease prevalence
      • 7.3.4.3. Competitive Scenario
      • 7.3.4.4. Regulatory Framework
      • 7.3.4.5. France Microfluidics Market, 2018 - 2030 (USD Million)
    • 7.3.5. Italy
      • 7.3.5.1. Key Country Dynamics
      • 7.3.5.2. Target disease prevalence
      • 7.3.5.3. Competitive Scenario
      • 7.3.5.4. Regulatory Framework
      • 7.3.5.5. Italy Microfluidics Market, 2018 - 2030 (USD Million)
    • 7.3.6. Spain
      • 7.3.6.1. Key Country Dynamics
      • 7.3.6.2. Target disease prevalence
      • 7.3.6.3. Competitive Scenario
      • 7.3.6.4. Regulatory Framework
      • 7.3.6.5. Spain Microfluidics Market, 2018 - 2030 (USD Million)
    • 7.3.7. Denmark
      • 7.3.7.1. Key Country Dynamics
      • 7.3.7.2. Target disease prevalence
      • 7.3.7.3. Competitive Scenario
      • 7.3.7.4. Regulatory Framework
      • 7.3.7.5. Denmark Microfluidics Market, 2018 - 2030 (USD Million)
    • 7.3.8. Sweden
      • 7.3.8.1. Key Country Dynamics
      • 7.3.8.2. Target disease prevalence
      • 7.3.8.3. Competitive Scenario
      • 7.3.8.4. Regulatory Framework
      • 7.3.8.5. Sweden Microfluidics Market, 2018 - 2030 (USD Million)
    • 7.3.9. Norway
      • 7.3.9.1. Key Country Dynamics
      • 7.3.9.2. Target disease prevalence
      • 7.3.9.3. Competitive Scenario
      • 7.3.9.4. Regulatory Framework
      • 7.3.9.5. Norway Microfluidics Market, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Microfluidics Market, 2018 - 2030 (USD Million)
    • 7.4.2. Japan
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Target disease prevalence
      • 7.4.2.3. Competitive Scenario
      • 7.4.2.4. Regulatory Framework
      • 7.4.2.5. Japan Microfluidics Market, 2018 - 2030 (USD Million)
    • 7.4.3. China
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Target disease prevalence
      • 7.4.3.3. Competitive Scenario
      • 7.4.3.4. Regulatory Framework
      • 7.4.3.5. China Microfluidics Market, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Target disease prevalence
      • 7.4.4.3. Competitive Scenario
      • 7.4.4.4. Regulatory Framework
      • 7.4.4.5. India Microfluidics Market, 2018 - 2030 (USD Million)
    • 7.4.5. Australia
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Target disease prevalence
      • 7.4.5.3. Competitive Scenario
      • 7.4.5.4. Regulatory Framework
      • 7.4.5.5. Australia Microfluidics Market, 2018 - 2030 (USD Million)
    • 7.4.6. Thailand
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Target disease prevalence
      • 7.4.6.3. Competitive Scenario
      • 7.4.6.4. Regulatory Framework
      • 7.4.6.5. Thailand Microfluidics Market, 2018 - 2030 (USD Million)
    • 7.4.7. South Korea
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Target disease prevalence
      • 7.4.7.3. Competitive Scenario
      • 7.4.7.4. Regulatory Framework
      • 7.4.7.5. South Korea Microfluidics Market, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Microfluidics Market, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Target disease prevalence
      • 7.5.2.3. Competitive Scenario
      • 7.5.2.4. Regulatory Framework
      • 7.5.2.5. Brazil Microfluidics Market, 2018 - 2030 (USD Million)
    • 7.5.3. Mexico
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Target disease prevalence
      • 7.5.3.3. Competitive Scenario
      • 7.5.3.4. Regulatory Framework
      • 7.5.3.5. Mexico Microfluidics Market, 2018 - 2030 (USD Million)
    • 7.5.4. Argentina
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Target disease prevalence
      • 7.5.4.3. Competitive Scenario
      • 7.5.4.4. Regulatory Framework
      • 7.5.4.5. Argentina Microfluidics Market, 2018 - 2030 (USD Million)
  • 7.6. MEA
    • 7.6.1. MEA Microfluidics Market, 2018 - 2030 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Target disease prevalence
      • 7.6.2.3. Competitive Scenario
      • 7.6.2.4. Regulatory Framework
      • 7.6.2.5. South Africa Microfluidics Market, 2018 - 2030 (USD Million)
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Target disease prevalence
      • 7.6.3.3. Competitive Scenario
      • 7.6.3.4. Regulatory Framework
      • 7.6.3.5. Saudi Arabia Microfluidics Market, 2018 - 2030 (USD Million)
    • 7.6.4. UAE
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Target disease prevalence
      • 7.6.4.3. Competitive Scenario
      • 7.6.4.4. Regulatory Framework
      • 7.6.4.5. UAE Microfluidics Market, 2018 - 2030 (USD Million)
    • 7.6.5. Kuwait
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Target disease prevalence
      • 7.6.5.3. Competitive Scenario
      • 7.6.5.4. Regulatory Framework
      • 7.6.5.5. Kuwait Microfluidics Market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis, 2023
  • 8.4. Company Profiles
    • 8.4.1. Illumina, Inc.
      • 8.4.1.1. Overview
      • 8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. F. Hoffmann-La Roche Ltd
      • 8.4.2.1. Overview
      • 8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. PerkinElmer, Inc
      • 8.4.3.1. Overview
      • 8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. Agilent Technologies, Inc
      • 8.4.4.1. Overview
      • 8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. Bio-Rad Laboratories, Inc
      • 8.4.5.1. Overview
      • 8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. Danaher Corporation
      • 8.4.6.1. Overview
      • 8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. Abbott
      • 8.4.7.1. Overview
      • 8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. Thermo Fisher Scientific Inc.
      • 8.4.8.1. Overview
      • 8.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. Standard BioTools, Inc.
      • 8.4.9.1. Overview
      • 8.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Strategic Initiatives